Clinical Trial Update: Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients [NA]

View source ↗

Summary

Clinical trial comparing qPCR to immunohistochemistry and FISH for detecting ALK fusion mutations in FFPE tissue from patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Nonsmall Cell Lung Cancer | NA | Status: COMPLETED